CRISPR systems in cancer therapeutics and diagnostics
Cellular and Molecular Biology · 31.03.2026 · 72 (3) · 8-18
DOI: 10.14715/cmb/2025.72.3.2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular and Molecular Biology, online erschienen am 31.03.2026. Verfasst von Mohsen Almakrami und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Heath Regional Lab and central Blood Bank Najran 66271, Saudi Arabia. mmalmakrami@moh.gov.sa. Hauptthemen laut MEDLINE: Neoplasms, CRISPR-Cas Systems. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ministry of Heath Regional Lab and central Blood Bank Najran 66271, Saudi Arabia. mmalmakrami@moh.gov.sa.
- Ministry of Heath Central Blood Bank Najran 66271, Saudi Arabia. zmumtaz@moh.gov.sa.
- Department, College of Science and Health Professions, - Al Ahsa, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia. aligh@ksau-hs.edu.sa.
- Department of Biology, College of Science, Taibah University, Medina, Saudi Arabia. aqurashi@taibahu.edu.sa.
Zitieren
APA
Almakrami, M., Ahmed, Z., Alali, G. M., & Alqurashi, A. (2026). CRISPR systems in cancer therapeutics and diagnostics. Cellular and Molecular Biology, 72(3), 8-18. https://doi.org/10.14715/cmb/2025.72.3.2
Vancouver
Almakrami M, Ahmed Z, Alali GM, Alqurashi A. CRISPR systems in cancer therapeutics and diagnostics. Cellular and Molecular Biology. 2026;72(3):8-18. doi:10.14715/cmb/2025.72.3.2
BibTeX
@article{Almakrami2026,
author = {Almakrami, Mohsen and Ahmed, Zubair and Alali, Ghadah M and Alqurashi, Abdulmajeed},
title = {CRISPR systems in cancer therapeutics and diagnostics},
journal = {Cellular and Molecular Biology},
year = {2026},
volume = {72},
number = {3},
pages = {8--18},
doi = {10.14715/cmb/2025.72.3.2}
}
EUVIMED